Last Updated: July 15, 2024 @ 9:13 am | ||
5180 | Herpes Simplex Virus 1/2 rRNA, TMA (NAAT) | |
Specimen: | Collect: |
Also Acceptable:
|
Submit: |
Also Acceptable:
| |
Rejection Criteria: |
| |
Stability: | Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: 1 Month(s); Incubated: Unacceptable | |
Methodology: |
| |
Performed: | Mon-Fri | |
Reported: | 1-3 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | Please see report for interpretive data. The Aptima Herpes Simplex Viruses 1 and 2 assay (Aptima HSV 1 and 2 assay) is an in vitro diagnostic nucleic acid amplification test (NAAT), using real time transcription mediated amplification (TMA), for the qualitative detection and differentiation of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) messenger RNA (mRNA) in clinician-collected swab specimens from anogenital skin lesions. The Aptima HSV 1 and 2 assay is intended for use as an aid in the diagnosis of HSV-1 and/or HSV-2 infections in symptomatic male and female patients. | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.